Qiu Yu-Fei, Hu Ji-Sheng, Wu Man, Liu Jia-Li, Li Chao-Yang, Yu Yi-Qing, Zeng Li-Juan, Yang Fen, Zheng Lan
School of Nursing, Hubei University of Chinese Medicine, Wuhan 430065, China.
Department of Dermatology, Traditional Chinese and Western Medicine Hospital of Wuhan, Tongji Medical college, Huazhong University of Science and Technology, Wuhan 430022, China; Department of Dermatology, Wuhan No.1 Hospital, Wuhan 430022, China.
Gen Hosp Psychiatry. 2024 Nov-Dec;91:143-150. doi: 10.1016/j.genhosppsych.2024.10.014. Epub 2024 Oct 22.
Depression and anxiety are common psychiatric symptoms in patients with Chronic Obstructive Pulmonary Disease (COPD). While face-to-face psychotherapy is a common option, tele-based interventions provide a more accessible alternative. However, a comprehensive synthesis of evidence from clinical trials for COPD patients has yet to be conducted.
This study aims to evaluate the effects of tele-based interventions in reducing depressive and anxiety symptoms in patients with COPD.
A systematic search of PubMed, EMBASE, the Cochrane Library, Web of Science, PsycINFO, and MEDLINE databases was conducted from inception to May 5, 2024. Eligible studies included Randomized Controlled Trials (RCTs) of people with COPD patients receiving tele-based interventions reporting on the outcomes of depression or anxiety. Data extraction and quality assessment were performed independently by two researchers. The quality of the included studies was assessed using the Cochrane risk-of-bias tool. Meta-analysis was performed using RevMan (version 5.4) and Stata (version 18.0) software.
Following the search, 9 RCTs with a total of 2064 patients with COPD were included. The meta-analysis revealed that tele-based interventions reduced depressive symptoms in patients with COPD (Standardized Mean Difference [SMD] = -0.15, 95 % CI -0.24 to -0.06; P = 0.001). The subgroup analysis indicated that the PHQ-9 (SMD = -0.24, 95 % CI -0.37 to -0.10; P = 0.001) was better at detecting changes in depressive symptoms compared to other scales; the first 3 months of intervention (SMD = -0.36, 95 % CI -0.52 to -0.19; P < 0.001) was the most pronounced improvement; and telehealth interventions were more effective (SMD = -0.30, 95 % CI -0.46 to -0.15; P < 0.001) than telemonitoring interventions. Tele-based interventions also reduced anxiety symptoms in patients with COPD (SMD = -0.12, 95 % CI -0.22 to -0.02; P = 0.02).
The evidence supports the efficacy of tele-based interventions in alleviating depression and anxiety symptoms in COPD patients. However, further large-scale and rigorously designed studies are warranted to strengthen the evidence.
抑郁和焦虑是慢性阻塞性肺疾病(COPD)患者常见的精神症状。虽然面对面心理治疗是一种常见选择,但基于远程的干预措施提供了一种更易获得的替代方案。然而,尚未对COPD患者临床试验的证据进行全面综合分析。
本研究旨在评估基于远程的干预措施对减轻COPD患者抑郁和焦虑症状的效果。
从数据库建库至2024年5月5日,对PubMed、EMBASE、Cochrane图书馆、科学网、PsycINFO和MEDLINE数据库进行系统检索。符合条件的研究包括COPD患者接受基于远程干预措施的随机对照试验(RCT),并报告抑郁或焦虑结果。由两名研究人员独立进行数据提取和质量评估。使用Cochrane偏倚风险工具评估纳入研究的质量。使用RevMan(5.4版)和Stata(18.0版)软件进行荟萃分析。
检索后,纳入9项RCT,共2064例COPD患者。荟萃分析显示,基于远程的干预措施可减轻COPD患者的抑郁症状(标准化均数差[SMD]= -0.15,95%可信区间-0.24至-0.06;P = 0.001)。亚组分析表明,与其他量表相比,PHQ-9(SMD = -0.24,95%可信区间-0.37至-0.10;P = 0.001)在检测抑郁症状变化方面更好;干预的前3个月(SMD = -0.36,95%可信区间-0.52至-0.19;P < 0.001)改善最为明显;远程医疗干预措施(SMD = -0.30,95%可信区间-0.46至-0.15;P < 0.001)比远程监测干预措施更有效。基于远程的干预措施也可减轻COPD患者的焦虑症状(SMD = -0.12,95%可信区间-0.22至-0.02;P = 0.02)。
证据支持基于远程的干预措施在减轻COPD患者抑郁和焦虑症状方面的疗效。然而,需要进一步开展大规模且设计严谨的研究以强化证据。